W e would like to highlight a recurring issue in the referral of patients presenting to district general hospitals (DGHs) with subarachnoid haemorrhage (SAH). Guidance from NICE suggests that patients with SAH should have rapid access to appropriate specialist care. 1 In reality, the referral, acceptance and transfer to a specialist centre is often far from rapid.
Many will recognise the scenario of a patient presenting to the emergency department with sudden onset of severe headache along with 'red flag' signs. They are scanned quickly and a diagnosis of SAH is made. On referral to Neuroscience Centre A, the history and scans are relayed to a neurosurgical trainee. Instead of receiving an immediate decision on whether the patient is suitable for acceptance and whether there is a bed available, there is often a time delay in which the patient' s history is further relayed to a consultant. If the patient is accepted by the team at Centre A, it is not uncommon to find, after a further time delay, that the intensive care unit is full. The process is then restarted by the DGH with Neuroscience Centre B. After more delays, if it is ascertained that no bed is available at this centre, Neuroscience Centre C must then be contacted. With no system in place to link images to neuroscience centres other than the centre immediately affiliated with the DGH, the process is more difficult. Some time having elapsed, and the patient' s condition possibly having deteriorated in this time, a further CT is sometimes requested before acceptance of the patient to Centre C, several hours after presentation of the patient to the DGH.
We propose a number of solutions to the problems outlined, which if agreed on a national level, could help eliminate the unnecessary delay, repetition and procrastination which often occur in the referral of SAH patients. We suggest the adoption of a single point of contact at a national level, either such as that seen with patients who need extra-corporal membrane oxygenation or such as that seen with co-ordinated transfer in UK paediatric services. 2, 3 We think consultant-to-consultant level discussion is warranted for the management of these patients. Additionally, national protocols could provide guidance to optimise management prior to transfer and could indicate clearly which patients would not be suitable for transfer. This could even help alleviate some of the demand for specialist beds as some patients could be managed in general intensive care units, as has been suggested for traumatic brain injury patients. 4 At the very least, we would like to see a national conversation on how best to serve patients with SAH presenting to DGHs, who need urgent access to neurosurgical expertise.
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Response: 'D minus -not good enough.'
T here is no argument with the case presented by Sodha and colleagues. Like so many services in the NHS, neurosurgery has developed in a rather ad hoc manner across the country. The latest Department of Health figures indicate that there are 249 specialist neurosciences critical care beds in England comprising 116 level 3 and 133 level 2 beds. 1 The beds are not evenly distributed between units, with the largest having 22 beds and the smallest only 6. A snapshot audit of neurocritical care capacity conducted in February 2006 found 84 patients with a primary neuroscience diagnosis who were managed in a non-neuroscience ICU. 2 Over a year, this would amount to roughly 4,000 patients managed in a district general ICU rather than a specialist unit. Recommendations from the Society of British Neurosurgeons (SBNS) in 2003 were for 10 neurocritical care beds per million population served. In 2009, the SBNS also stated that 'admission to a regional neurosurgical service for life-saving emergency surgery should never be delayed' and that 'lack of critical care beds must not be a reason for refusing admission. ' So which patient with a subarachnoid haemorrhage (SAH)
